Palmitolethanolamide

GettyImages - upper respiratory tract infection / Mohammed Haneefa Nizamudeen

Study: URTI symptoms reduced with PEA Levagen+

By Olivia Haslam

An industry funded study concludes the branded palmitoylethanolamide (PEA) ingredient ‘Levagen+’ is safe and effective in reducing the incidence and symptoms associated with upper respiratory tract infections (URTIs).

© Bunyos / Getty Images

News in Brief

ANVISA grants novel food certification for Levagen

By Stephen Daniells

Gencor’s Levagen, a clinically studied form of palmitolethanolamide (PEA), has been granted novel foods certification by Brazil’s National Health Surveillance Agency ANVISA.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All